Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aldolase A as a prognostic factor and mediator of progression via inducing epithelial–mesenchymal transition in gastric cancer

11 Jul 2018

Abstract excerpt

Glycolysis is regarded as the hallmark of cancer development and progression, which involves a multistep enzymatic reaction. This study aimed to explore the clinicopathological significance and potential role of glycolytic enzyme aldolase A (ALDOA) in the carcinogenesis and progression of gastric cancer (GC). ALDOA was screened from three paired liver metastasis tissues and primary GC tissues and further explored...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related Molecular Pathways
Share to Cancer Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29992789
DOI: 10.1111/jcmm.13732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aldolase A as a prognostic factor and mediator of progression via inducing epithelial–mesenchymal transition in gastric cancerPMID 29992789Read ↗

Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinomaSemantic proximity Read ↗

ALDOC and PGK1 coordinately induce glucose metabolism reprogramming and promote development of colorectal cancerSemantic proximity Read ↗

FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.Semantic proximity Read ↗

Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal CancerSemantic proximity Read ↗

ENO3 promotes colorectal cancer progression by enhancing cell glycolysisSemantic proximity Read ↗

The Prognostic Value of Metabolic Genes in Gastric AdenocarcinomaSemantic proximity Read ↗

Construction and Validation of a Prognostic Prediction Model for Gastric Cancer Using a Series of Genes Related to Lactate MetabolismSemantic proximity Read ↗

Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic targetSemantic proximity Read ↗

Comprehensive Molecular Characterization and Identification of Prognostic Signature in Stomach Adenocarcinoma on The Basis of Energy-Metabolism-Related GenesSemantic proximity Read ↗

Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in gliomaSemantic proximity Read ↗

Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancerSemantic proximity Read ↗

Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.